Smooth Muscle

Cytokinetics is extending its validated drug discovery platform in contractility to create new therapeutic opportunities based on smooth muscle contractility and is central to the pathophysiology of a broad array of common conditions including hypertension and asthma. The smooth muscle contractile apparatus provides a novel handle for the therapy of these conditions. Cytokinetics is in a unique position to potentially create the next generation of smooth muscle relaxants for the treatment of asthma and hypertension based on the biology of smooth muscle contraction.